Dobutamine Hydrochloride in Dextrose (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Dobutamine Hydrochloride in Dextrose drug offered from Baxter Healthcare Corporation. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | Dobutamine Hydrochloride |
SUBSTANCE NAME: | DOBUTAMINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1993-09-27 |
END MARKETING DATE: | 0000-00-00 |
Dobutamine Hydrochloride in Dextrose HUMAN PRESCRIPTION DRUG Details:
Item Description | Dobutamine Hydrochloride in Dextrose from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/100mL) |
START MARKETING DATE: | 1993-09-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-1073_9b33db96-6e6e-4e15-9217-337c1202a885 |
PRODUCT NDC: | 0338-1073 |
APPLICATION NUMBER: | NDA020255 |
Other DOBUTAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: